Equities

Touyun Biotech Group Ltd

Touyun Biotech Group Ltd

Actions
IndustrialsGeneral Industrials
  • Price (HKD)0.17
  • Today's Change-0.005 / -2.86%
  • Shares traded110.00k
  • 1 Year change-64.95%
  • Beta0.8533
Data delayed at least 15 minutes, as of Sep 20 2024 03:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3614494
Total Receivables, Net97132132
Total Inventory153633
Prepaid expenses2.873.993.12
Other current assets, total116.205.91
Total current assets162322268
Property, plant & equipment, net311381436
Goodwill, net000
Intangibles, net00.281.62
Long term investments134184319
Note receivable - long term0.20----
Other long term assets------
Total assets6078881,025
LIABILITIES
Accounts payable184638
Accrued expenses171512
Notes payable/short-term debt00296
Current portion long-term debt/capital leases17920114
Other current liabilities, total166147169
Total current liabilities381410530
Total long term debt2061948.12
Total debt385395319
Deferred income tax------
Minority interest222017
Other liabilities, total------
Total liabilities608624555
SHAREHOLDERS EQUITY
Common stock112112112
Additional paid-in capital1,9081,9081,908
Retained earnings (accumulated deficit)(2029)(1762)(1571)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total7.896.3521
Total equity(0.85)264470
Total liabilities & shareholders' equity6078881,025
Total common shares outstanding2,8062,8062,806
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.